Skip to main content

Advertisement

Table 3 Secondary outcomes at final follow-up

From: Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction

Outcome Number of event (%) Statin vs. non-statin
Statin (n = 441) Non-statin (n = 441) HR (95% CI) P value
All-cause mortality 250 (56.7) 271 (61.5) .70 (.59, .84) <.001
Hemorrhage stroke 4 (.9) 2 (.5) 1.23 (.22, 6.84) .810
Heart failure 59 (13.4) 44 (10.0) 1.08 (.73, 1.60) .714
Acute hepatitis 1 (.2) 3 (.7) .22 (.02, 2.16) .194
Rhabdomyolysis 4 (.9) 1 (.2) 3.36 (.38, 30.06) .279
Newly diagnosed dementia 0 (.0) 1 (.2) NA NA
Newly diagnosed malignancy 14 (3.2) 9 (2.0) 1.09 (.46, 2.56) .844
  1. CI confidence interval, HR hazard ratio, NA not applicable